XP Inc. XP
15.08 USD +0.52 (+3.57%)
Nov 4, 2026, 3:26 PM EST
14.79 Day range 15.16
13.78 52-week range 32.73
- YTD
- -7.88%
- 1 year
- -16.69%
Analyst view
Consensus: buy
Buy
Price target (mean) 24.56 +62.9% upside
Now 15.08
- Target (low)
- 14.88
- Target (mean)
- 24.56
- Target (high)
- 36.00
Ratings (0m) 13 9 buy · 4 hold · 0 sell
- Strong buy3
- Buy6
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.78 | 2.73 – 2.90 | 2.47 | +12.5% | 5.12B | +9.9% | 6 |
| Next quarter | 2.90 | 2.79 – 3.02 | 2.56 | +13.4% | 5.45B | +10.0% | 5 |
| Current year | 10.90 | 10.53 – 11.35 | 9.81 | +11.1% | 20.11B | +9.2% | 9 |
| Next year | 12.38 | 11.18 – 13.86 | 10.90 | +13.6% | 22.51B | +11.9% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Oct 8, 2026 | UBS | Maintained | Buy | Buy |
| Oct 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 6, 2026 | Itau BBA | Upgrade | Market Perform | Outperform |
| Sep 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 31, 2026 | Itau BBA | Upgrade | Market Perform | Outperform |
| Jun 3, 2026 | UBS | Maintained | Buy | Buy |
| Apr 2, 2026 | UBS | Maintained | Buy | Buy |
| Jan 20, 2026 | Jefferies | Initiated | — | Buy |
| Dec 16, 2025 | UBS | Maintained | Buy | Buy |
| Oct 16, 2025 | UBS | Maintained | Buy | Buy |
| Sep 24, 2025 | Citigroup | Maintained | Buy | Buy |
| Jun 10, 2025 | UBS | Maintained | Buy | Buy |
| Jun 4, 2025 | Goldman Sachs | Upgrade | Neutral | Buy |
| May 21, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| May 21, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| May 13, 2025 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Apr 7, 2025 | UBS | Maintained | Neutral | Buy |
| Jan 27, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jan 24, 2025 | UBS | Upgrade | Neutral | Buy |
| Dec 10, 2024 | B of A Securities | Downgrade | Buy | Neutral |
| Nov 26, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 16, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 30, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 11, 2024 | UBS | Downgrade | Buy | Neutral |
| Jun 17, 2024 | B of A Securities | Maintained | Buy | Buy |
| Jun 5, 2024 | Citigroup | Maintained | Buy | Buy |
| Apr 30, 2024 | Goldman Sachs | Downgrade | Buy | Neutral |
| Apr 23, 2024 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Mar 22, 2024 | Citigroup | Maintained | Buy | Buy |